Literature DB >> 26912446

Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale.

Christopher C Rowe1, Gareth Jones2, Vincent Doré3, Svetlana Pejoska2, Laura Margison2, Rachel S Mulligan2, J Gordon Chan2, Kenneth Young2, Victor L Villemagne4.   

Abstract

UNLABELLED: A common quantitative output value for PET measures of β-amyloid (Aβ) binding across tracers and methods would allow better comparison of data across sites and application of universal diagnostic and prognostic values. A method has recently been developed that generates a unit of measurement called the centiloid. We applied this method to 2-[2-(18)F-fluoro-6-(methylamino)-3-pyridinyl]-1-benzofuran-5-ol ((18)F-NAV4694) and (11)C-Pittsburgh compound B ((11)C-PiB) Aβ images to derive the scaling factor required to express tracer binding in centiloids.
METHODS: Fifty-five participants, including 10 young controls (33 ± 7 y old), underwent both (11)C-PiB and (18)F-NAV4694 imaging no more than 3 mo apart, with the images acquired 50-70 min after tracer injection. The images were spatially normalized and analyzed using the standard centiloid method and regions (cortex and whole-cerebellum reference) downloaded from the Global Alzheimer Association Interactive Network website.
RESULTS: SUV ratios (SUVRs) showed a strong correlation in tracer binding ((18)F-NAV4694 SUVR = 1.09 × (11)C-PiB SUVR - 0.08, R(2) = 0.99). The equation to convert (18)F-NAV4694 to centiloids [100 × ((18)F-NAV4694 SUVR - 1.028)/1.174] was similar to a published equation for (11)C-PiB [100 × ((11)C-PiB SUVR - 1.009)/1.067]. In the young controls, the variance ratio ((18)F-NAV4694 centiloid SD divided by (11)C-PiB centiloid SD) was 0.85.
CONCLUSION: The results for both (11)C-PiB and (18)F-NAV4694 can now be expressed in centiloids, an important step that should allow better clinical and research use of Aβ imaging. The standard centiloid method also showed that (18)F-NAV4694 has slightly higher Aβ binding and lower variance than (11)C-PiB, important properties for detecting early Aβ deposition and change over time.
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  Alzheimer’s disease; amyloid imaging; beta-amyloid; centiloid; standardization

Mesh:

Substances:

Year:  2016        PMID: 26912446     DOI: 10.2967/jnumed.115.171595

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  23 in total

1.  Spatiotemporal relationship between subthreshold amyloid accumulation and aerobic glycolysis in the human brain.

Authors:  Manu S Goyal; Brian A Gordon; Lars E Couture; Shaney Flores; Chengjie Xiong; John C Morris; Marcus E Raichle; Tammie L-S Benzinger; Andrei G Vlassenko
Journal:  Neurobiol Aging       Date:  2020-09-01       Impact factor: 4.673

Review 2.  Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.

Authors:  Victor L Villemagne; Vincent Doré; Samantha C Burnham; Colin L Masters; Christopher C Rowe
Journal:  Nat Rev Neurol       Date:  2018-02-16       Impact factor: 42.937

3.  β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3.

Authors:  Pierrick Bourgeat; Vincent Doré; Samantha C Burnham; Tammie Benzinger; Duygu Tosun; Shenpeng Li; Manu Goyal; Pamela LaMontagne; Liang Jin; Christopher C Rowe; Michael W Weiner; John C Morris; Colin L Masters; Jurgen Fripp; Victor L Villemagne
Journal:  Neuroimage       Date:  2022-07-30       Impact factor: 7.400

Review 4.  Novel Tracers and Radionuclides in PET Imaging.

Authors:  Christian Mason; Grayson R Gimblet; Suzanne E Lapi; Jason S Lewis
Journal:  Radiol Clin North Am       Date:  2021-09       Impact factor: 1.947

5.  Nonlinear Distributional Mapping (NoDiM) for harmonization across amyloid-PET radiotracers.

Authors:  Michael J Properzi; Rachel F Buckley; Jasmeer P Chhatwal; Michael C Donohue; Cristina Lois; Elizabeth C Mormino; Keith A Johnson; Reisa A Sperling; Aaron P Schultz
Journal:  Neuroimage       Date:  2018-11-17       Impact factor: 6.556

6.  Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology.

Authors:  Renaud La Joie; Nagehan Ayakta; William W Seeley; Ewa Borys; Adam L Boxer; Charles DeCarli; Vincent Doré; Lea T Grinberg; Eric Huang; Ji-Hye Hwang; Milos D Ikonomovic; Clifford Jack; William J Jagust; Lee-Way Jin; William E Klunk; Julia Kofler; Orit H Lesman-Segev; Samuel N Lockhart; Val J Lowe; Colin L Masters; Chester A Mathis; Catriona L McLean; Bruce L Miller; Daniel Mungas; James P O'Neil; John M Olichney; Joseph E Parisi; Ronald C Petersen; Howard J Rosen; Christopher C Rowe; Salvatore Spina; Prashanthi Vemuri; Victor L Villemagne; Melissa E Murray; Gil D Rabinovici
Journal:  Alzheimers Dement       Date:  2018-10-19       Impact factor: 21.566

7.  Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies.

Authors:  Pierrick Bourgeat; Vincent Doré; James Doecke; David Ames; Colin L Masters; Christopher C Rowe; Jurgen Fripp; Victor L Villemagne
Journal:  Neuroimage       Date:  2020-11-26       Impact factor: 6.556

Review 8.  Molecular Imaging Approaches in Dementia.

Authors:  Victor L Villemagne; Frederik Barkhof; Valentina Garibotto; Susan M Landau; Agneta Nordberg; Bart N M van Berckel
Journal:  Radiology       Date:  2021-01-19       Impact factor: 11.105

9.  Association of education with Aβ burden in preclinical familial and sporadic Alzheimer disease.

Authors:  Julie Gonneaud; Christophe Bedetti; Alexa Pichet Binette; Tammie L S Benzinger; John C Morris; Randall J Bateman; Judes Poirier; John C S Breitner; Sylvia Villeneuve
Journal:  Neurology       Date:  2020-08-05       Impact factor: 9.910

10.  Socioeconomic Status Mediates Racial Differences Seen Using the AT(N) Framework.

Authors:  Karin L Meeker; Julie K Wisch; Darrell Hudson; Dean Coble; Chengjie Xiong; Ganesh M Babulal; Brian A Gordon; Suzanne E Schindler; Carlos Cruchaga; Shaney Flores; Aylin Dincer; Tammie L Benzinger; John C Morris; Beau M Ances
Journal:  Ann Neurol       Date:  2020-11-07       Impact factor: 11.274

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.